These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37373354)

  • 1. Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review.
    Castillo DR; Park D; Jeon WJ; Joung B; Lee J; Yang C; Pham B; Hino C; Chong E; Shields A; Nguyen A; Brothers J; Liu Y; Zhang KK; Cao H
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.
    Pizzi M; Agostinelli C; Righi S; Gazzola A; Mannu C; Galuppini F; Fassan M; Visentin A; Piazza F; Semenzato GC; Rugge M; Sabattini E
    Histopathology; 2017 Nov; 71(5):769-777. PubMed ID: 28628241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL6, MUM1, and CD10 expression in mantle cell lymphoma.
    Gualco G; Weiss LM; Harrington WJ; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):103-8. PubMed ID: 19826251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma.
    McCluggage WG; Catherwood M; Alexander HD; McBride HA; Smith ME; Morris TC
    Histopathology; 2002 Nov; 41(5):414-20. PubMed ID: 12405909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases.
    Xu J; Medeiros LJ; Saksena A; Wang M; Zhou J; Li J; Yin CC; Tang G; Wang L; Lin P; Li S
    Oncotarget; 2018 Feb; 9(14):11441-11450. PubMed ID: 29545910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas.
    Bai M; Agnantis NJ; Skyrlas A; Tsanou E; Kamina S; Galani V; Kanavaros P
    Mod Pathol; 2003 May; 16(5):471-80. PubMed ID: 12748254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic Features and Treatment of CD10-Positive Mantle Cell Lymphoma: A Case Report and Review of Literature.
    Hino C; Pham B; Gray AL; Wang J; Castillo DR; Akhtari M; Liu Y
    Pathol Oncol Res; 2022; 28():1610588. PubMed ID: 36091937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.
    Cozzolino I; Varone V; Picardi M; Baldi C; Memoli D; Ciancia G; Selleri C; De Rosa G; Vetrani A; Zeppa P
    Cancer Cytopathol; 2016 Feb; 124(2):135-43. PubMed ID: 26414904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.
    Akhter A; Mahe E; Street L; Pournazari P; Perizzolo M; Shabani-Rad MT; Stewart DA; Mansoor A
    J Clin Pathol; 2015 Oct; 68(10):844-8. PubMed ID: 26124315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma.
    Kreher S; Jöhrens K; Strehlow F; Martus P; Borowiec K; Radke J; Heppner F; Roth P; Thiel E; Pietsch T; Weller M; Korfel A
    Neuro Oncol; 2015 Jul; 17(7):1016-21. PubMed ID: 25817328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological features of mantle cell lymphoma patients with co-expression of CD10 and BCL-6: a retrospective study.
    Chen W; Liu H; Wang P; Li G
    Transl Cancer Res; 2021 Nov; 10(11):4786-4793. PubMed ID: 35116331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique case of mantle cell lymphoma with an aberrant CD5-/CD10+ immunophenotype and typical morphology.
    Sriganeshan V; Blom TR; Weissmann DJ
    Arch Pathol Lab Med; 2008 Aug; 132(8):1346-9. PubMed ID: 18684040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell differentiation immunophenotypes in classical Hodgkin lymphomas.
    Bai M; Panoulas V; Papoudou-Bai A; Horianopoulos N; Kitsoulis P; Stefanaki K; Rontogianni D; Agnantis NJ; Kanavaros P
    Leuk Lymphoma; 2006 Mar; 47(3):495-501. PubMed ID: 16396774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle cell lymphoma with aberrant expression of CD10.
    Zanetto U; Dong H; Huang Y; Zhang K; Narbaitz M; Sapia S; Kostopoulos I; Liu H; Du MQ; Bacon CM
    Histopathology; 2008 Jul; 53(1):20-9. PubMed ID: 18518902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
    Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of de novo diffuse large B-cell lymphoma with a translocation of c-myc and immunoglobulin genes.
    Kikuchi A; Nakamura N; Kuze T; Sasaki Y; Abe M; Ohno H; Akasaka T; Nakamura S; Ohshima K; Ando K
    Leuk Res; 2008 Aug; 32(8):1176-82. PubMed ID: 18460403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 18. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
    Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
    Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.
    van Imhoff GW; Boerma EJ; van der Holt B; Schuuring E; Verdonck LF; Kluin-Nelemans HC; Kluin PM
    J Clin Oncol; 2006 Sep; 24(25):4135-42. PubMed ID: 16943530
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wang L; Tang G; Medeiros LJ; Xu J; Huang W; Yin CC; Wang M; Jain P; Lin P; Li S
    Haematologica; 2021 May; 106(5):1381-1389. PubMed ID: 32273477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.